0241.HK

Online medical services provider Alibaba Health Information Technology Ltd. (0241.HK) said Wednesday its revenue rose 10.2% year-on-year to 14.27 billion yuan ($1.98 billion) in the six months through September. It credited the growth to a 67.5% jump in revenue from its pharmaceutical e-commerce platform business, which was partly offset by a 9.4% drop in revenue from its healthcare and digital services business.

The company’s net profit during the period, the first half of its fiscal year, surged by 72.5% to 770 million yuan. It attributed the strong gains to the revenue increase, as well as improving operational efficiencies for its self-operated pharmaceutical business, including its introduction of more top brands and expansion of its partnership channels.

The company’s stock rose 3.3% to HK$4.27 in early Thursday trade in Hong Kong.

By A. Au

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Goodbaby makes strollers

Investors left crying as U.S. tariffs hit Goodbaby

The world’s leading producer of baby strollers and car seats is getting socked by a double whammy of U.S. tariffs and China’s baby bust Key Takeaways: Goodbaby reported its revenue…
Seeking a profile boost, Boxihe pivots to Hong Kong IPO

Seeking a profile boost, Boxihe pivots to Hong Kong IPO

The maker of high-performance outdoor clothing is betting on rising demand for its Pelliot apparel range in China’s still relatively untapped market   Key Takeaways: The company’s pre-IPO backers include Tencent…
Damai sells concert tickets

Damai rides China’s offline leisure boom to bumper profits

The company’s dominance in live entertainment ticketing and IP franchises has turbocharged its revenue, despite persistent consumer complaints and monopolistic behavior Key Takeaways: Damai’s profit rose around 50% in the…